TREATMENT REGIMEN FOR THE TREATMENT OF NEUROLOGICAL DISEASES OR CONDITIONS
Application
US20260076940A1
Kind: A1
Mar 19, 2026
Assignee
Accure Therapeutics, S.L.
Inventors
Pablo VILLOSLADA DIAZ
Abstract
It relates to BN201 or a pharmaceutically acceptable salt thereof, for use in the treatment of acute optic neuritis that is efficacious for at least 28 days wherein the treatment is administered once a day for 5-7 days.
CPC Classifications
A61K 31/4015
A61K 31/18
A61K 31/40
A61P 27/06
Filing Date
2025-11-25
Application No.
19401124